Publicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (2)

2023

  1. Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker

    Cells, Vol. 12, Núm. 6

2021

  1. CPEB alteration and aberrant transcriptome-polyadenylation lead to a treatable SLC19A3 deficiency in Huntington’s disease

    Science Translational Medicine, Vol. 13, Núm. 613